Helmy Eltoukhy - 14 Mar 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Co-Chief Executive Officer, Director
Signature
/s/ John Saia, as attorney-in-fact for Helmy Eltoukhy
Issuer symbol
GH
Transactions as of
14 Mar 2023
Net transactions value
+$2,448,836
Form type
4
Filing time
16 Mar 2023, 17:24:52 UTC
Previous filing
23 Nov 2021
Next filing
13 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Purchase $2,223,908 +84,452 +4.3% $26.33 2,040,638 14 Mar 2023 Direct F1
transaction GH COMMON STOCK Purchase $224,928 +8,600 +0.42% $26.15 2,049,238 15 Mar 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average price of shares purchased at prices that ranged from $26.245 to $26.50.
F2 Represents the weighted average price of shares purchased at prices that ranged from $26.13 to $26.27.